Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

September 30, 2011

Study Completion Date

March 31, 2012

Conditions
Brain and Central Nervous System TumorsNeurofibromatosis Type 1
Interventions
DRUG

carboplatin

DRUG

vinblastine sulfate

Trial Locations (21)

10032

Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center, New York

13210

SUNY Upstate Medical University Hospital, Syracuse

15213

Children's Hospital of Pittsburgh, Pittsburgh

35294

Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham, Birmingham

38105

St. Jude Children's Research Hospital, Memphis

55455

Masonic Cancer Center at University of Minnesota, Minneapolis

60614

Children's Memorial Hospital - Chicago, Chicago

63110

Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis, St Louis

75390

Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas

92868

Children's Hospital of Orange County, Orange

98105

Children's Hospital and Regional Medical Center - Seattle, Seattle

20010-2970

Children's National Medical Center, Washington D.C.

46202-5289

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

02115

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston

48109-0286

C.S. Mott Children's Hospital at University of Michigan Medical Center, Ann Arbor

45229-3039

Cincinnati Children's Hospital Medical Center, Cincinnati

97239-3098

Oregon Health and Science University Cancer Institute, Portland

19104-9786

Children's Hospital of Philadelphia, Philadelphia

77030-2399

Baylor University Medical Center - Houston, Houston

M5G 1X8

Hospital for Sick Children, Toronto

H3T 1C5

Hopital Sainte Justine, Montreal

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT00352495 - Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma | Biotech Hunter | Biotech Hunter